• Mashup Score: 7

    Prostate cancer is a major cause of disease burden, with an estimated 313,780 new cases (the highest incidence in males aside from skin cancer, comprising 30% of all new cases) and approximately 33,363 deaths (the second highest cause of mortality in males and constituting 11% of all cancer-related deaths) in the United States in 2025. 1 As with many other cancers, somatic genomic testing has both prognostic and predictive capabilities and may affect treatment decision making for patients with metastatic

    Tweet Tweets with this article
    • Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: @ASCO Guideline Clinical Insights. #mpc #pcsm Co-authored by @vedangiri, @BryanRumble, @lu_KevinLuMD et al. https://t.co/H2M2rK5Cjz